Guidance for industry : use of serological tests to reduce the risk of transmission of trypanosoma cruzi infection in whole blood and blood components for transfusion and human cells, tissues, and cellular and tissue-based products (HCT/Ps).

Bibliographic Details
Corporate Author:	Center for Biologics Evaluation and Research (U.S.)
Format:	Government Document eBook
Language:	English
Published:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2009]
Subjects:	Trypanosoma cruzi > United States > Prevention. Blood > Transfusion > Government policy > United States. Cell transplantation > Government policy > United States. Transplantation of organs, tissues, etc. > Government policy > United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS113497

Description
Item Description:	Title from PDF title page (viewed on June 4, 2009). "Draft guidance". "March 2009". Includes bibliographical references (pages 12-14). Electronic resource.
Physical Description:	i, 14 pages : digital, PDF file.
Format:	Mode of access: Internet at the FDA web site. Address as of 6/4/09: http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Tissue/ucm126098.pdf ; current access is available via PURL.